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Abstract 
Background: To compare intra-articular plus subacromial corticosteroid 
injection with a single intra-articular injection in diabetics with adhesive 
capsulitis. 
Materials and Methods: A total of fifty-four diabetic patients were 
randomized into corticosteroid injection in both intra-articular and subacromial 
sites (group A) and one intra-articular injection (group B). Pain by a visual 
analog scale (VAS), shoulder range of motion, and functional state by the 
American Shoulder and Elbow Score was assessed before injection, and at 
follow-up months. 
Results: The pain VAS scores of group A were considerably lower than group 
B at the first-month follow-up visit (P=0.01). The range of motion in forward-
elevation and internal rotation at three-month follow-up visits was significantly 
higher in group A than in group B (P=0.035, P=0.04, respectively). No notable 
differences in the range of motion in forward-elevation, internal rotation, and 
external rotation between groups at the final follow-up visit were seen. Though 
a significant difference in the ASES between groups at the third-month follow-
up visit (P=0.03), the ASES score at the final sixth-month follow-up was 
similar in both groups (P=0.7). 
Conclusion: In diabetic adhesive capsulitis of the shoulder, subacromial 
combined with intra-articular steroid injections has superior subjective 
outcomes compared to single intra-articular corticosteroid injection.  
Keywords: Adhesive capsulitis, Diabetes mellitus, Corticosteroid, Intra-articular 
injection 
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Adhesive capsulitis of the shoulder as a common 
affliction has a prevalence of 2–5% in the general adult 
population and up to 20% in diabetic patients (1-3). 
This disease was first described by Codman in 1934 
(4). Adhesive capsulitis is a clinical diagnosis based on 
a history of the gradual progression of severe shoulder 
pain with the gradual limitation of active and passive 
glenohumeral joint range of motions. The main 
pathogenesis of this disease remains unknown, 
although features associated with it include older than 
forty years old, trauma, female sex, diabetes, 
autoimmune disease, prolonged immobilization, 
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stroke, thyroid disease, and myocardial infarction (5). 
Even though typically considered as a self-limiting 
condition, the natural history of adhesive capsulitis is 
not completely understood, and the latest trials have 
reported that it can cause longer-term disability over 
several years (6, 7). The general non-operative 
approaches used for the management of frozen 
shoulder consist of non-steroidal anti-inflammatory 
drugs (NSAIDs), corticosteroid local injections, 
physiotherapy, manipulation, and hydrodilation (8). 
Up to now, there is no consensus as to which is most 
helpful (9). Intra-articular corticosteroid injections can 
result in unsatisfactory outcomes in the management of 
adhesive capsulitis, with improved shoulder 
movements and quick pain relief (10). The 
management of adhesive capsulitis in diabetic patients 
is more difficult, and they have more resistance to 
conservative treatment. An intra-articular or 
subacromial corticosteroid injection can be a useful 
treatment approach for diabetic patients with the 
benefits of locally delivering and potentially less 
systemic side effects (11). However, the efficacy of 
intra-articular or subacromial corticosteroid injections 
in adhesive capsulitis patients with diabetes has not 
been well assessed. The aim of this study is to evaluate 
the clinical efficacy of intra-articular and subacromial 
corticosteroid injection compared with single intra-





Between February 2016 and October 2019, 67 diabetic 
patients suffering from shoulder adhesive capsulitis 
were referred to us. Shoulder adhesive capsulitis was 
defined as the presence of shoulder pain with a 
limitation of the passive movements of the 
glenohumeral joint (more than 25% or 30⁰ in at least 
two directions including forward-elevation, external 
rotation, and internal rotation) compared to the 
contralateral normal shoulder (12). In the case of 
bilateral involvement, the more limited joint was 
selected for study analysis. Patients were investigated 
with conventional radiographs (true anteroposterior, 
axial, and 30⁰ caudal tilt views) and Magnetic 
resonance imaging (MRI). To rule out other causes of 
the limitation of shoulder range of motion including 
calcific tendinitis, rotator cuff tear, or osteoarthritis. 
We excluded all patients with symptomatic calcific 
tendinitis, shoulder osteoarthritis, glenohumeral 
arthritis, cerebrovascular accident, a history of 
shoulder trauma, previous intra-articular therapy, a 
known blood coagulation disorder; partial rotator cuff 
tear with more than 50% tear and full-thickness rotator 
cuff tear, the written informed consent was obtained 
from all participants from all patients of this study. The 
patients were diagnosed with diabetes based on a 
confirmed history of diabetes or as the result of an oral 
glucose tolerance test and HbA1c value (13). 
Randomization was conducted via an automatically 
generated randomization list. Patients were divided 
into two groups: one group of patients underwent 
injection in both intra-articular and subacromial sites 
(group A) and another group received only one intra-
articular injection (group B). The severity of adhesive 
capsulitis was classified (7, 14-16): painful stage with 
a subtle onset of pain and gradual loss of movement 
(phase 1), frozen stage with subsidence of pain and 
global stiffness (phase 2), and resolution stage (phase 
3). All of the patients received the same protocol for 
home stretching physical therapy at the first visit, 
which highlights a four-quadrant stretching protocol in 
internal rotation, external rotation, forward elevation, 
and cross-body adduction (17). The patients were 
recommended to do their exercises at home at least 
three times a day and were prescribed oral non-
steroidal anti-inflammatory drugs if needed. The study 
protocol was approved by our university ethics 
committee. A corticosteroid injection solution 
contained 40 mg triamcinolone acetonide (1 cc) with 4 
mL of 2% lidocaine and 5 mL distilled water in 10 cc 
syringe (for intra-articular injection just 5cc of this 
cocktail used and for two side injection 5 mL for intra-
articular and 5 mL for subacromial space). 
Triamcinolone was chosen because it is the minimal 
water-soluble corticosteroid preparation and so has the 
least systemic spill-over with the longest efficacy 
duration (14). While local corticosteroid injection can 
lead to the increment of the blood glucose levels, there 
is no evidence regarding intra-articular injection 
induce adverse side effects (11). The injected dose of 
40 mg was believed to be sufficient to get satisfactory 
outcomes in the treatment of shoulder adhesive 
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capsulitis (10). The intra-articular steroid injections 
were carried out by the same orthopedic surgeon. After 
placing the patient in the sitting position, the index 
finger of the surgeon’s free hand was put on the 
coracoid process tip while the thumb is placed at the 
back of the shoulder 1.5 cm below and 1.5 cm medial 
to the posterolateral angle of the acromial in the soft 
spot area. The needle was inserted near the surgeons' 
thumb and toward the tip of the index finger. The 
needle was inserted into the posterior a capsul of the 
glenohumeral joint. For injection into the SA space; 
after palpation of the distal, lateral, and posterior edges 
of the acromion the needle is inserted exactly inferior 
to the posterolateral edge of the acromion. Then the 
corticosteroid solution flow freely into the space 
without any resistance or significant discomfort to the 
patient. All patients in both groups were prescribed 
NSAIDs and analgesics for pain relief if needed. The 
home stretching exercise protocol was started one day 
later. A complete physical examination was conducted 
by the same surgeon. The shoulder range of motion 
was assessed using a goniometer with passive internal 
rotation to the back while the patient was seated, 
external rotation at 0⁰ abduction, and forward elevation 
and recorded as whole numbers without decimal. The 
internal rotation to the back was measured as the 
highest bony landmark reached with the extended 
thumb, which was consequently transformed to a value 
between 0 and 10 without decimal based on the 
constant score to ease statistical analysis (18). The pain 
severity was analyzed via a 10-cm visual analog scale 
(VAS, 0 representing ‘no pain’ and 10 representing 
‘the most severe pain’) ruler to one decimal place, and 
the functional assessment was performed by use of 
American Shoulder and Elbow Score (ASES) 
determined before the injection and at the end of first, 
the third, and sixth month of follow-up.We considered 
two-scale differences of the VAS as the significant 
between-groups difference since the reported minimal 
clinically notable difference of the numeric pain rating 
scale in broad patient populations with different 
musculoskeletal characteristics has been reported to be 
two points (19). Statistical analysis was carried out 
using SPSS 22 software. Demographic comparisons 
were conducted via the student t-test for age and 
symptom duration and Χ2 tests for sex distribution. 
Improvement in each follow-up between the groups 
and the differences between pre-injection and each 
follow-up period were evaluated between the groups 
via the student t-tests. Additional Bonferroni 





Group A included 27 patients, 10 men (37%) and 17 
women (63%), who were a mean age of 52.3 years 
(range, 37-69 years). The mean duration of symptoms 
was 5.7 months (range, 1.1-19 months). Group B 
consisted of 27 patients, 12 men (44%) and 15 women 
(56%), with a mean age of 56.5 years (range, 39-74 
years). The mean duration of symptoms was 2.9 
months (range, 1-10 months). The two groups had no 
statistically significant difference regarding age, 
gender, affected shoulder, symptom duration, disease 
stage, hemoglobin A1C level, and prevalence of 
insulin-dependent patients. Patient baseline 
Table 1: Patient baseline characteristics. 
P-value Group B2 Group A1 Variable 
 27 27 Patients 










0.61 7.3 (3-16) 5.7 (1.1-19) Symptom's duration, month 
(range) 
1 Group A: patients underwent injection in both intra-articular and subacromial 
sites. 
2 Group B: patients received only one intra-articular injection. 
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characteristics are summarized in Table 1. At the initial 
visit, no intergroup differences were found between 
groups. The pain VAS scores of group A were 
considerably lower than group B at the first-month 
follow-up visit (P = 0.01) (Figure 1). The range of 
motion in forward-elevation and internal rotation at the 
three-month follow-up visit was significantly higher in 
group A than in group B (P = 0.035, P= 0.04 
respectively) (Figure 2). There were no notable 
differences in the range of motion in forward-
elevation, internal rotation (Figure 3), and external 
rotation (Figure 4) between groups at the final six-
month follow-up visit. Although there was a significant 
difference in the ASES between groups at the three-
month follow-up visit (P= 0.03) the ASES score at the 
final six-month follow-up was similar in both groups 




There are some reports that a single intra-articular 
steroid injection is useful to relieve shoulder pain and 
disability in patients with frozen shoulders (2, 5, 18). 
By considering synovial inflammation as the probable 
pathophysiology of frozen shoulder intra-articular 
steroid injection can be acceptable for its management. 
The most important outcome of our survey was that 
double intra-articular along with subacromial 
corticosteroid injection in diabetic patients 
demonstrated superior results in the subjective pain 
suffering and early functional recovery in comparison 
with single intra-articular corticosteroid injection. 
While there were no considerable between-group 
differences in pain, range of motion and functional 
score at the end of the six-month follow-up, double site 
corticosteroid injection leads to faster functional 
improvement and reduce pain perception. We found 
significant differences in pain perception one month 
after injection and functional improvement at the end 
of three months. Adhesive capsulitis composes of 
inflammatory and fibrotic changes (1). Intra-articular 
corticosteroid injection results in chemical ablation of 
the synovitis prevent the subsequent progression of 
fibrosis and influence the ordinary history of the 
disease (15). Shoulder adhesive capsulitis is the most 
frequent musculoskeletal pathology in diabetic patients 
(20). It has been reported in recent studies that diabetic 
patients usually have more joint motion limitations in 
comparison with a healthy population. The incidence 
of shoulder adhesive capsulitis in the general 
population is expected to be 2–5%, while in diabetic 
patients it increases to 20% (1, 2). On the other hand, 
in diabetic patients' shoulders, adhesive capsulitis was 
shown to be more persistent and unresponsive to 
conservative management. Even though the main 
pathophysiology of adhesive capsulitis in diabetic 
patients is unknown, a structural alteration in collagen 
as a consequence of glycosylation of the collagen 
protein and cell injury due to final product 
accumulation after advanced glycosylation can justify 
this association (21, 22). Although operative treatment 
 
Figure 1. Pain severity using VAS (before the injection,1month,3 months, and 6 months after the injection). 
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has been displayed to decrease the natural history of 
this disease, surgery, and anesthesia-associated 
complications particularly in diabetic patients are 
major concerns (16). For that reason, intra-articular 
corticosteroid injection can be a valuable treatment 
approach for diabetic patients. Rizk et al in a 
randomized trial compared four groups: intrabursal 
lidocaine injection, intrabursal methylprednisolone, 
and lidocaine injection, intra-articular 
methylprednisolone and lidocaine injection, and intra-
articular lidocaine injection (23). They found no 
significant difference between intrabursal injections 
 
Figure 2. Forward elevation of the shoulder (before the injection,1month,3 months, and 6 months after the injection). 
 
Figure 3. Internal rotation of the shoulder (before injection, 1month, 3 months, and 6 months after the injection). 
 
Figure 4. External rotation of the shoulder (before injection, 1month, 3 months, and 6 months after the injection). 
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and intra-articular injections. Finally, partial, 
temporary pain relief was seen in two-thirds of the 
steroid-injected patients. However, we experienced 
that single intra-articular steroid injection has not had 
always satisfactory outcomes. Some authors believed 
that the low accuracy of intra-articular injections 
without image guidance is the major reason for 
unsatisfactory outcomes (24-26). On the other hand, 
one of the most frequent causes of the limited range of 
motion of the shoulder is rotator cuff disorders such as 
tendinopathy, calcification, and partial-thickness tears. 
In this survey, we performed an MRI investigation to 
rule out mentioned pathologies. Because of reporting 
few studies about the systemic effects of intra-articular 
corticosteroid injection especially on the blood glucose 
levels (11). Additional researches will be necessary to 
verify the most effective dosage and potential side 
effects of intra-articular along with subacromial 
corticosteroid injection and other pain reliving 
modalities (25-26). Our prospective, randomized, 
comparative trial concluded that because of the 
relatively lesser accuracy of blind injections into the 
glenohumeral joint, subacromial steroid injections 
along with intra-articular injections show superior 
outcomes in subjective pain perception and early 
functional recovery compared to the single intra-
articular corticosteroid injection. Given the absence of 
verified adverse events in these patients, Subacromial 
steroid injections along with intra-articular injections 
is recommended as a valuable treatment approach in 
diabetic patients with shoulder adhesive capsulitis. 
 
Conclusion 
Because subacromial steroid injections along with 
intra-articular injections show superior outcomes in 
subjective pain perception and early functional 
recovery compared to the single intra-articular 
corticosteroid injection, it is recommended as a 
valuable treatment approach in diabetic patients with 




The researchers are grateful Sports Medicine and Knee 
Research Center that collaborated with this research. 
 
 
Conflicts of Interest  





1. Page RS, McGee SL, Eng K, Brown G, Beattie S, Collier F, et al. 
Adhesive capsulitis of the shoulder: protocol for the adhesive 
capsulitis biomarker (AdCaB) study. BMC Musculoskelet Disord. 
2019;20(1):145. 
2. Aslani MA, Mirzaee F, Farahanchi Baradaran A, Zafarani Z, 
Aslani H. Clinical Results of Platelet-Rich Plasma in Frozen 
 
Figure 5. ASES of the patients (before injection, 1month, 3 months and 6 months after the injection). 
Intra-Articular along with Subacromial Corticosteroid Injection in Diabetic …                                                 Aslani et al. 
Vol 6, No 2, Spring 2021 
187 
Shoulder. J Cell Mol Anesth. 2020;5(2):74-8. 
3. Kayalha H, Ebtehaj M, Shafikhani AA, Emami S. Effect of 
Addition of Ondansetron or Magnesium to Lidocaine on Duration of 
Analgesia of Intravenous Regional Anesthesia in Elective Upper 
Extremities Surgery: Comparative Study. J Cell Mol Anesth. 
2020;4(3):88-95. 
4. Dias R, Cutts S, Massoud S. Frozen shoulder. BMJ. 
2005;331(7530):1453-6. 
5. Bal A, Eksioglu E, Gulec B, Aydog E, Gurcay E, Cakci A. 
Effectiveness of corticosteroid injection in adhesive capsulitis. Clin 
Rehabil. 2008;22(6):503-12. 
6. Hand C, Clipsham K, Rees JL, Carr AJ. Long-term outcome of 
frozen shoulder. J Shoulder Elbow Surg. 2008;17(2):231-6. 
7. Gross C, Dhawan A, Harwood D, Gochanour E, Romeo A. 
Glenohumeral joint injections: a review. Sports Health. 
2013;5(2):153-9. 
8. Neviaser AS, Hannafin JA. Adhesive capsulitis: a review of current 
treatment. Am J Sports Med. 2010;38(11):2346-56. 
9. de Oliveira FCL, Pairot de Fontenay B, Bouyer LJ, Desmeules F, 
Roy JS. Kinesiotaping for the Rehabilitation of Rotator Cuff-Related 
Shoulder Pain: A Randomized Clinical Trial. Sports Health. 
2021;13(2):161-72. 
10. Lorbach O, Anagnostakos K, Scherf C, Seil R, Kohn D, Pape D. 
Nonoperative management of adhesive capsulitis of the shoulder: oral 
cortisone application versus intra-articular cortisone injections. J 
Shoulder Elbow Surg. 2010;19(2):172-9. 
11. Habib GS, Abu-Ahmad R. Lack of effect of corticosteroid 
injection at the shoulder joint on blood glucose levels in diabetic 
patients. Clin Rheumatol. 2007;26(4):566-8. 
12. Matsumura N, Kaneda K, Oki S, Kimura H, Suzuki T, Iwamoto 
T, et al. Factors related to large bone defects of bipolar lesions and a 
high number of instability episodes with anterior glenohumeral 
instability. J Orthop Surg Res. 2021;16(1):255. 
13. Barman A, Mukherjee S, Sahoo J, Maiti R, Rao PB, Sinha MK, 
et al. Single Intra-articular Platelet-Rich Plasma Versus Corticosteroid 
Injections in the Treatment of Adhesive Capsulitis of the Shoulder: A 
Cohort Study. Am J Phys Med Rehabil. 2019;98(7):549-57. 
14. Chambler AF, Carr AJ. The role of surgery in frozen shoulder. J 
Bone Joint Surg Br. 2003;85(6):789-95. 
15. Hannafin JA, Chiaia TA. Adhesive capsulitis. A treatment 
approach. Clin Orthop Relat Res. 2000(372):95-109. 
16. Rill BK, Fleckenstein CM, Levy MS, Nagesh V, Hasan SS. 
Predictors of outcome after nonoperative and operative treatment of 
adhesive capsulitis. Am J Sports Med. 2011;39(3):567-74. 
17. Griggs SM, Ahn A, Green A. Idiopathic adhesive capsulitis. A 
prospective functional outcome study of nonoperative treatment. J 
Bone Joint Surg Am. 2000;82(10):1398-407. 
18. Ryans I, Montgomery A, Galway R, Kernohan WG, McKane R. 
A randomized controlled trial of intra-articular triamcinolone and/or 
physiotherapy in shoulder capsulitis. Rheumatology (Oxford). 
2005;44(4):529-35. 
19. Farrar JT, Young JP, Jr., LaMoreaux L, Werth JL, Poole MR. 
Clinical importance of changes in chronic pain intensity measured on 
an 11-point numerical pain rating scale. Pain. 2001;94(2):149-58. 
20. Smith LL, Burnet SP, McNeil JD. Musculoskeletal 
manifestations of diabetes mellitus. Br J Sports Med. 2003;37(1):30-
5. 
21. Vishwanath V, Frank KE, Elmets CA, Dauchot PJ, Monnier VM. 
Glycation of skin collagen in type I diabetes mellitus. Correlation with 
long-term complications. Diabetes. 1986;35(8):916-21. 
22. Khashaee S, Manaheji H, Nikzad N, Zaringhalam J. Anti-
hyperalgesic and anti-inflammatory effects of long term calcium 
administration during adjuvant-induced arthritis in rats. J Cell Mol 
Anesth. 2016;1(1):12-8. 
23. Rizk TE, Pinals RS, Talaiver AS. Corticosteroid injections in 
adhesive capsulitis: investigation of their value and site. Arch Phys 
Med Rehabil. 1991;72(1):20-2. 
24. Sethi PM, Kingston S, Elattrache N. Accuracy of anterior intra-
articular injection of the glenohumeral joint. Arthroscopy. 
2005;21(1):77-80 
25. Nazemian V, Nasseri B, Manaheji H, Zaringhalam J. Effects of 
mesenchymal stem cells conditioned medium on behavioral aspects 
of inflammatory arthritic pain induced by CFA adjuvant. J Cell Mol 
Anesth. 2016;1(2):47-55. 
26. Nasseri B, Nazemian V, Manaheji H, Mousavi Z, Zaringhalam J. 
Microglia are involved in pain related behaviors during the acute and 
chronic phases of arthritis inflammation. J Cell Mol Anesth. 
2016;1(4):137-45. 
 
